The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development
Animal models of COVID-19 facilitate the development of vaccines and antivirals against SARS-CoV-2. The efficacy of antivirals or vaccines may differ in different animal models with varied degrees of disease. Here, we introduce a mouse model expressing human angiotensin-converting enzyme 2 (ACE2). I...
        Saved in:
      
    
          | Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | Taylor & Francis Group
    
        2024-12-01 | 
| Series: | Emerging Microbes and Infections | 
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2024.2353302 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
 
       